Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...

Discover how a new eye drop treatment may prevent the loss of vision associated with dry age-related macular degeneration, ...

The research team led by Dr. Moon-Hyeong Seo from the Natural Product Drug Development Center at the Korea Institute of ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Explore the intricate details of the Age-related Macular Degeneration Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Age-related Macular ...

Investigators conducted a meta-analysis of randomized controlled trials to assess the efficacy and safety of brolucizumab ...

Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Many people consider the symptoms of aging and blurred vision as a simple presbyopia. However, this may be an early symptom ...

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced central ...

Although intravitreal faricimab helped to decrease central subfield thickness (CST) in patients with eyes previously treated ...

The Korea Institute of Science and Technology (KIST) announced on the 18th that it held a signing ceremony for technology ...